Showing results (6801-6810 of 10,083) with videos related to
Sort By:
Pageof 1,009
Current Pharmaceutical Design|January 5, 2013
Antiplatelet drug resistance and variability in response: the role of antiplatelet therapy monitoringUdaya S Tantry, Paul A GurbelCurrent Pharmaceutical Design|January 5, 2013
PCSK9 inhibition - a novel mechanism to treat lipid disorders?Maciej Banach, Manfredi Rizzo, Milan Obradovic, et al.Current Pharmaceutical Design|May 31, 2012
Removal of the tag from His-tagged ILYd4, a human CD59 inhibitor, significantly improves its physical properties and its activityLin Wu, Sanbao Su, Fengming Liu, et al.Current Pharmaceutical Design|May 18, 2012
Role of farletuzumab in epithelial ovarian carcinomaDanijela Jelovac, Deborah K ArmstrongCurrent Pharmaceutical Design|May 9, 2012
Hepatic injury to the newborn liver due to drugsPeter Van Eyken, Sonia Nemolato, Gavino Faa, et al.Current Pharmaceutical Design|December 29, 2012
Therapy against ischemic injuryGiacinta Guarini, Alda Huqi, Paola Capozza, et al.Current Pharmaceutical Design|January 3, 2013
Pioglitazone and cancer: angel or demon?Michael S Kostapanos, Moses S Elisaf, Dimitri P MikhailidisCurrent Pharmaceutical Design|January 3, 2013
A review of the cardiovascular and anti-atherogenic effects of ghrelinManfredi Rizzo, Ali A Rizvi, Emina Sudar, et al.Current Pharmaceutical Design|January 3, 2013
Modern treatment of infection and ischaemia to reduce major amputation in the diabetic footMichael EdmondsCurrent Pharmaceutical Design|January 3, 2013
Current options and perspectives in the treatment of diabetic neuropathyTamás Várkonyi, Zsuzsanna Putz, Katalin Keresztes, et al.Pageof 1,009